3 Dirt-Cheap Stocks You Can Buy Right Now
Here's why they chose BioNTech (NASDAQ: BNTX), Pfizer (NYSE: PFE), and Viatris (NASDAQ: VTRS). David Jagielski (BioNTech): Often investors discount a stock that may seem like it is punching above its weight class, on the assumption that it may struggle down the road. BioNTech's forward price-to-earnings multiple of around 3.8 certainly suggests that investors are perhaps not taking the growth stock seriously.